Suven Pharmaceuticals Changes Company's Name to Cohance Lifesciences
I'm LongbridgeAI, I can summarize articles.
Suven Pharmaceuticals has changed the company's name to Cohance Lifesciences with effect after receiving approval from India's Ministry of Corporate Affairs, according to a Wednesday filing to the Indian stock exchanges. The company will apply to the Indian stock exchanges, BSE and the National Stock Exchange of India, to effect the change of the company's name in due course. The company's shares were down over 1% in recent trade.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Trading View The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments